Shoko Tsukube

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study

Kazuhiro Suzuki, Nobuaki Matsubara, Hirotaka Kazama et al. · Japanese Journal of Clinical Oncology · 2019 · 42 citations · Full text

Electrochemical detection of HbA1c, a maker for diabetes, using a flow immunoassay system

Tsuyoshi Tanaka, Shoko Tsukube, Kojiro Izawa et al. · Biosensors and Bioelectronics · 2006 · 40 citations

Engineering, Biochemistry, Bioelectrochemistry +13

Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan

Nobuaki Matsubara, Kazuhiro Suzuki, Hirotaka Kazama et al. · Journal of Geriatric Oncology · 2020 · 27 citations · Full text

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study

Hideyasu Matsuyama, Nobuaki Matsubara, Hirotaka Kazama et al. · BMC Cancer · 2020 · 22 citations · Full text

Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantus<sup>®</sup>

Masayuki Kobayashi, Shoko Tsukube, Yukio Ikeda et al. · Journal of Diabetes Mellitus · 2014 · 12 citations · Full text